| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | ATRX SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B CHD6 HELLS | 1.08e-13 | 37 | 148 | 10 | GO:0140658 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B KIF18A ATP13A4 ATP7B ATRX MYO1D DDX60 SMARCAL1 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 KIF9 RAD54B ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 ATP2A2 HELLS | 2.52e-11 | 614 | 148 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B KIF18A ATP13A4 ATP7B ATRX DDX60 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAB44 KIF9 RND1 ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 CDC42 ATP2A2 RAC1 RAC2 RAC3 | 9.84e-11 | 775 | 148 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B KIF18A ATP13A4 ATP7B ATRX DDX60 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 KIF9 ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 ATP2A2 | 1.01e-10 | 441 | 148 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 DNA2 HELLS | 1.76e-10 | 158 | 148 | 13 | GO:0004386 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B KIF18A ATP13A4 ATP7B ATRX DDX60 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAB44 KIF9 RND1 ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 CDC42 ATP2A2 RAC1 RAC2 RAC3 | 5.42e-10 | 839 | 148 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B KIF18A ATP13A4 ATP7B ATRX DDX60 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAB44 KIF9 RND1 ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 CDC42 ATP2A2 RAC1 RAC2 RAC3 | 5.56e-10 | 840 | 148 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B KIF18A ATP13A4 ATP7B ATRX DDX60 COQ8B CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAB44 KIF9 RND1 ABCB11 DDX53 CHD6 KIF18B DNA2 CARNS1 CDC42 ATP2A2 RAC1 RAC2 RAC3 | 5.56e-10 | 840 | 148 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | ATRX SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B CHD6 DNA2 HELLS | 2.72e-09 | 127 | 148 | 11 | GO:0008094 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EXOSC9 ATRX DDX60 SMARCAL1 POLR2B QTRT2 CHD9 CHD8 CHD1 BTAF1 RAD54L2 POLR3B AGO1 POP1 RAD54B INTS11 DDX53 CHD6 DNA2 HELLS | 6.52e-08 | 645 | 148 | 20 | GO:0140640 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ATRX SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B CHD6 DNA2 HELLS | 4.22e-06 | 262 | 148 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.37e-05 | 7 | 148 | 3 | GO:0004703 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 5.46e-05 | 2 | 148 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | nucleoside binding | 6.30e-05 | 11 | 148 | 3 | GO:0001882 | |
| GeneOntologyMolecularFunction | ribonucleoside binding | 1.63e-04 | 3 | 148 | 2 | GO:0032549 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 3.24e-04 | 4 | 148 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 5.38e-04 | 5 | 148 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 7.37e-04 | 55 | 148 | 4 | GO:0051879 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP13A4 ATP7B SLC25A14 AQP8 CCDC51 NDUFS1 SLC13A4 SLC10A6 KCNQ1 SLC13A5 DMAC2L SEC61A1 ATP2A2 | 8.07e-04 | 627 | 148 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | kinase binding | KIF13B GRK5 BARD1 GCKR RAD54L2 LDHB RND1 FBXO5 KCNQ1 LRBA CDC42 MAP2K6 MUSK RAC1 FAM83A HTT RAC3 | 8.55e-04 | 969 | 148 | 17 | GO:0019900 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP13A4 ATP7B SLC2A8 SLC25A14 SLC7A6 NDUFS1 SLC13A4 SLC10A6 ABCB11 SLC13A5 ATP2A2 | 8.74e-04 | 477 | 148 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | EXOSC9 DDX60 POLR2B QTRT2 POLR3B AGO1 POP1 RAD54B INTS11 DDX53 | 1.12e-03 | 417 | 148 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.37e-03 | 163 | 148 | 6 | GO:0031072 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 1.48e-03 | 8 | 148 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP13A4 ATP7B SLC25A14 AQP8 CCDC51 NDUFS1 SLC13A4 CLCA1 SLC10A6 KCNQ1 SLC13A5 DMAC2L SEC61A1 ATP2A2 | 1.54e-03 | 758 | 148 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.82e-03 | 70 | 148 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.87e-03 | 118 | 148 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | thioesterase binding | 2.36e-03 | 10 | 148 | 2 | GO:0031996 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.38e-03 | 36 | 148 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.38e-03 | 36 | 148 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP13A4 ATP7B SLC2A8 SLC25A14 AQP8 SLC7A7 SLC7A6 CCDC51 NDUFS1 SLC13A4 CLCA1 SLC10A6 ABCB11 KCNQ1 SLC13A5 DMAC2L SEC61A1 ATP2A2 | 2.85e-03 | 1180 | 148 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.87e-03 | 11 | 148 | 2 | GO:0005388 | |
| Domain | SNF2_N | ATRX SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B CHD6 HELLS | 3.72e-14 | 32 | 147 | 10 | IPR000330 |
| Domain | SNF2_N | ATRX SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B CHD6 HELLS | 3.72e-14 | 32 | 147 | 10 | PF00176 |
| Domain | Helicase_C | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 4.69e-11 | 107 | 147 | 12 | PF00271 |
| Domain | HELICc | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 4.69e-11 | 107 | 147 | 12 | SM00490 |
| Domain | Helicase_C | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 5.24e-11 | 108 | 147 | 12 | IPR001650 |
| Domain | HELICASE_CTER | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 5.85e-11 | 109 | 147 | 12 | PS51194 |
| Domain | HELICASE_ATP_BIND_1 | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 5.85e-11 | 109 | 147 | 12 | PS51192 |
| Domain | DEXDc | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 5.85e-11 | 109 | 147 | 12 | SM00487 |
| Domain | Helicase_ATP-bd | ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RAD54B DDX53 CHD6 HELLS | 6.52e-11 | 110 | 147 | 12 | IPR014001 |
| Domain | P-loop_NTPase | ADCY10 KIF13B KIF18A ATRX MYO1D DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 KIF9 RND1 RAD54B ABCB11 DDX53 CHD6 KIF18B DNA2 CDC42 RAC1 RAC2 RAC3 HELLS | 1.09e-08 | 848 | 147 | 25 | IPR027417 |
| Domain | RHO | 3.98e-07 | 20 | 147 | 5 | PS51420 | |
| Domain | - | ADCY10 ATRX DDX60 SMARCAL1 CHD9 CHD8 CHD1 BTAF1 RAD54L2 RND1 RAD54B ABCB11 DDX53 CHD6 DNA2 CDC42 RAC1 RAC2 RAC3 HELLS | 1.65e-06 | 746 | 147 | 20 | 3.40.50.300 |
| Domain | BRK | 9.39e-06 | 6 | 147 | 3 | SM00592 | |
| Domain | BRK_domain | 9.39e-06 | 6 | 147 | 3 | IPR006576 | |
| Domain | BRK | 9.39e-06 | 6 | 147 | 3 | PF07533 | |
| Domain | - | TOGARAM2 CUL9 BTAF1 UNC45A UNC45B UTP20 LRBA CFAP69 TBCD HTT | 1.06e-05 | 222 | 147 | 10 | 1.25.10.10 |
| Domain | GPCR_kinase | 1.63e-05 | 7 | 147 | 3 | IPR000239 | |
| Domain | Chromo_domain | 3.46e-05 | 24 | 147 | 4 | IPR023780 | |
| Domain | Chromo | 4.81e-05 | 26 | 147 | 4 | PF00385 | |
| Domain | ARM-like | TOGARAM2 CUL9 BTAF1 UNC45A UNC45B UTP20 LRBA CFAP69 TBCD HTT | 5.64e-05 | 270 | 147 | 10 | IPR011989 |
| Domain | UNC45-central | 6.15e-05 | 2 | 147 | 2 | PF11701 | |
| Domain | RabGDI | 6.15e-05 | 2 | 147 | 2 | IPR000806 | |
| Domain | RNA_pol_Rpb2_4 | 6.15e-05 | 2 | 147 | 2 | PF04566 | |
| Domain | RNA_pol_Rpb2_4 | 6.15e-05 | 2 | 147 | 2 | IPR007646 | |
| Domain | UCS_central_dom | 6.15e-05 | 2 | 147 | 2 | IPR024660 | |
| Domain | CHROMO_1 | 6.51e-05 | 28 | 147 | 4 | PS00598 | |
| Domain | CHROMO_2 | 6.51e-05 | 28 | 147 | 4 | PS50013 | |
| Domain | ARM-type_fold | TOGARAM2 CUL9 BTAF1 UNC45A PIK3CA UNC45B UTP20 LRBA CFAP69 TBCD HTT | 7.88e-05 | 339 | 147 | 11 | IPR016024 |
| Domain | Chromodomain-like | 1.12e-04 | 32 | 147 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.26e-04 | 33 | 147 | 4 | IPR000953 | |
| Domain | CHROMO | 1.26e-04 | 33 | 147 | 4 | SM00298 | |
| Domain | - | 1.84e-04 | 3 | 147 | 2 | 2.40.270.10 | |
| Domain | RNA_pol_RPB2_OB-fold | 1.84e-04 | 3 | 147 | 2 | IPR014724 | |
| Domain | RNA_pol_bsu_CS | 1.84e-04 | 3 | 147 | 2 | IPR007121 | |
| Domain | DNA-dir_RNA_pol_su2_6 | 1.84e-04 | 3 | 147 | 2 | IPR007120 | |
| Domain | RNA_pol_Rpb2_7 | 1.84e-04 | 3 | 147 | 2 | PF04560 | |
| Domain | RNA_pol_Rpb2_2 | 1.84e-04 | 3 | 147 | 2 | PF04561 | |
| Domain | RNA_pol_Rpb2_5 | 1.84e-04 | 3 | 147 | 2 | PF04567 | |
| Domain | RNA_pol_Rpb2_1 | 1.84e-04 | 3 | 147 | 2 | PF04563 | |
| Domain | RNA_pol_Rpb2_3 | 1.84e-04 | 3 | 147 | 2 | PF04565 | |
| Domain | RNA_pol_Rpb2_5 | 1.84e-04 | 3 | 147 | 2 | IPR007647 | |
| Domain | RNA_pol_Rpb2_3 | 1.84e-04 | 3 | 147 | 2 | IPR007645 | |
| Domain | RNA_pol_bsu_protrusion | 1.84e-04 | 3 | 147 | 2 | IPR007644 | |
| Domain | RNA_pol_Rpb2_2 | 1.84e-04 | 3 | 147 | 2 | IPR007642 | |
| Domain | RNA_pol_Rpb2_7 | 1.84e-04 | 3 | 147 | 2 | IPR007641 | |
| Domain | - | 1.84e-04 | 3 | 147 | 2 | 2.40.50.150 | |
| Domain | RNA_POL_BETA | 1.84e-04 | 3 | 147 | 2 | PS01166 | |
| Domain | - | 1.84e-04 | 3 | 147 | 2 | 3.90.1110.10 | |
| Domain | DNA-dir_RNA_pol_su2 | 1.84e-04 | 3 | 147 | 2 | IPR015712 | |
| Domain | RNA_pol_Rpb2_6 | 1.84e-04 | 3 | 147 | 2 | PF00562 | |
| Domain | Kinesin_motor_CS | 2.97e-04 | 41 | 147 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 3.58e-04 | 43 | 147 | 4 | IPR027640 | |
| Domain | DUF1736 | 3.65e-04 | 4 | 147 | 2 | IPR013618 | |
| Domain | GDI | 3.65e-04 | 4 | 147 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 3.65e-04 | 4 | 147 | 2 | IPR018203 | |
| Domain | DUF1736 | 3.65e-04 | 4 | 147 | 2 | PF08409 | |
| Domain | - | 3.92e-04 | 44 | 147 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 3.92e-04 | 44 | 147 | 4 | PF00225 | |
| Domain | KISc | 3.92e-04 | 44 | 147 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.92e-04 | 44 | 147 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.92e-04 | 44 | 147 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.92e-04 | 44 | 147 | 4 | PS50067 | |
| Domain | HEAT | 5.48e-04 | 48 | 147 | 4 | PF02985 | |
| Domain | Na/sul_symport | 6.06e-04 | 5 | 147 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 6.06e-04 | 5 | 147 | 2 | PF00939 | |
| Domain | TPR_1 | 7.25e-04 | 90 | 147 | 5 | IPR001440 | |
| Domain | TPR_1 | 7.25e-04 | 90 | 147 | 5 | PF00515 | |
| Domain | Clathrin_mu_CS | 9.04e-04 | 6 | 147 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 9.04e-04 | 6 | 147 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 9.04e-04 | 6 | 147 | 2 | PS00991 | |
| Domain | HEAT | 1.12e-03 | 58 | 147 | 4 | IPR000357 | |
| Domain | APC_su10/DOC_dom | 1.26e-03 | 7 | 147 | 2 | IPR004939 | |
| Domain | DOC | 1.26e-03 | 7 | 147 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.26e-03 | 7 | 147 | 2 | PF03256 | |
| Domain | APC10 | 1.26e-03 | 7 | 147 | 2 | SM01337 | |
| Domain | - | 2.00e-03 | 32 | 147 | 3 | 3.40.1110.10 | |
| Domain | - | 2.00e-03 | 32 | 147 | 3 | 2.70.150.10 | |
| Domain | HEAT_REPEAT | 2.26e-03 | 70 | 147 | 4 | PS50077 | |
| Domain | TPR-like_helical_dom | 2.50e-03 | 233 | 147 | 7 | IPR011990 | |
| Domain | RGS | 2.60e-03 | 35 | 147 | 3 | PF00615 | |
| Domain | RGS | 2.60e-03 | 35 | 147 | 3 | SM00315 | |
| Domain | ATPase_P-typ_cyto_domN | 2.60e-03 | 35 | 147 | 3 | IPR023299 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.60e-03 | 35 | 147 | 3 | IPR002464 | |
| Domain | Clathrin_mu | 2.66e-03 | 10 | 147 | 2 | IPR001392 | |
| Domain | RGS | 2.82e-03 | 36 | 147 | 3 | PS50132 | |
| Domain | ATPase_P-typ_P_site | 2.82e-03 | 36 | 147 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.82e-03 | 36 | 147 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.82e-03 | 36 | 147 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.05e-03 | 37 | 147 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.05e-03 | 37 | 147 | 3 | PF00122 | |
| Domain | Elongated_TPR_rpt_dom | 3.23e-03 | 11 | 147 | 2 | IPR023114 | |
| Domain | Adap_comp_sub | 3.23e-03 | 11 | 147 | 2 | PF00928 | |
| Domain | DEAH_ATP_HELICASE | 3.29e-03 | 38 | 147 | 3 | PS00690 | |
| Domain | RGS | 3.55e-03 | 39 | 147 | 3 | IPR016137 | |
| Domain | TPR | 3.56e-03 | 129 | 147 | 5 | SM00028 | |
| Domain | Clathrin_sm-chain_CS | 3.86e-03 | 12 | 147 | 2 | IPR000804 | |
| Domain | TPR_repeat | 4.05e-03 | 133 | 147 | 5 | IPR019734 | |
| Domain | Ras | 4.45e-03 | 136 | 147 | 5 | PF00071 | |
| Domain | ANX | 4.53e-03 | 13 | 147 | 2 | SM00335 | |
| Domain | AA_permease_2 | 4.53e-03 | 13 | 147 | 2 | PF13520 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 2.12e-06 | 12 | 117 | 4 | M39408 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 1.90e-05 | 7 | 117 | 3 | M47538 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 3.03e-05 | 8 | 117 | 3 | M5291 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 3.91e-05 | 76 | 117 | 6 | M1749 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 6.41e-05 | 10 | 117 | 3 | M47727 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 1.93e-04 | 35 | 117 | 4 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 1.93e-04 | 35 | 117 | 4 | M773 | |
| Pubmed | 6.31e-10 | 11 | 150 | 5 | 18786395 | ||
| Pubmed | Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. | 1.15e-08 | 7 | 150 | 4 | 9490022 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | KIF18A EXOSC9 SMARCAL1 BARD1 CHD8 UNC45A ZNF106 POP1 OSBPL5 UTP20 KIF18B CDC42 ATP2A2 | 2.99e-08 | 410 | 150 | 13 | 26949251 |
| Pubmed | MYO1D LCP1 GDI1 GDI2 LDHB AP3M1 EXOC5 CDC42 ATP2A2 SNTB2 RAC1 RAC2 RAC3 | 3.08e-08 | 411 | 150 | 13 | 36652389 | |
| Pubmed | rac, a novel ras-related family of proteins that are botulinum toxin substrates. | 7.86e-08 | 3 | 150 | 3 | 2674130 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 12384416 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 16081809 | ||
| Pubmed | Signaling and cytoskeletal requirements in erythroblast enucleation. | 7.86e-08 | 3 | 150 | 3 | 22461493 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 22123845 | ||
| Pubmed | Rapid Remodeling of Invadosomes by Gi-coupled Receptors: DISSECTING THE ROLE OF Rho GTPases. | 7.86e-08 | 3 | 150 | 3 | 26740622 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 30387892 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 34943902 | ||
| Pubmed | HK1 MYO1D MYCBP2 CUL9 CHD8 CHD1 LCP1 GDI1 GDI2 NDUFS1 ANAPC1 POP1 UTP20 ATP2A2 PNP | 1.70e-07 | 653 | 150 | 15 | 22586326 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RIOK1 ACACB POLR2B TOGARAM2 CHD9 NEB LCP1 AP3M1 ZNF106 DIP2A RBM46 LRBA HELLS | 2.74e-07 | 497 | 150 | 13 | 36774506 |
| Pubmed | Structure of the TPR domain of p67phox in complex with Rac.GTP. | 3.14e-07 | 4 | 150 | 3 | 11090627 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 9642115 | ||
| Pubmed | Essential role of Rac1 and Rac3 GTPases in neuronal development. | 3.22e-07 | 14 | 150 | 4 | 19126596 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.30e-07 | 208 | 150 | 9 | 33230847 | |
| Pubmed | 5.69e-07 | 222 | 150 | 9 | 37071664 | ||
| Pubmed | RIOK1 ATP7B MYCBP2 POLR2B CHD1 MCM10 WLS NDUFS1 ZNF106 POLR3B FBXO5 GUCY1B1 ANAPC1 CHD6 TMEM35A | 7.32e-07 | 733 | 150 | 15 | 34672954 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 15023524 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 17682062 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 16174757 | ||
| Pubmed | PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. | 7.81e-07 | 5 | 150 | 3 | 22043008 | |
| Pubmed | RIOK1 ATRX RBL1 CHD8 BTAF1 RAD54L2 WLS TGFBI DIP2A POP1 RAD54B DNA2 SEC61A1 HELLS | 9.60e-07 | 650 | 150 | 14 | 38777146 | |
| Pubmed | KIF13B HK1 ACACB ATRX MYO1D ZNF174 GRK5 GRK6 CCNO RAD54L2 NEB LCP1 NDUFS1 RND1 TESMIN CHD6 SEC61A1 CFAP69 ATP2A2 RAC1 RAC3 | 1.10e-06 | 1442 | 150 | 21 | 35575683 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 9438836 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 10506199 | ||
| Pubmed | Small GTP-binding proteins and the regulation of the actin cytoskeleton. | 1.56e-06 | 6 | 150 | 3 | 7888179 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK1 MYCBP2 POLR2B CYP51A1 QTRT2 BTAF1 UNC45A WLS GDI2 LDHB AP3M1 NDUFS1 ANAPC1 DNA2 SEC61A1 ATP2A2 TBCD PNP HELLS | 2.19e-06 | 1257 | 150 | 19 | 37317656 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATRX ZNF174 BARD1 CHD9 CHD8 CHD1 BTAF1 MCM10 RAD54B CHD6 KIF18B RAC1 HELLS | 2.58e-06 | 608 | 150 | 13 | 36089195 |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 11517230 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 8672451 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EXOSC9 RIOK1 HK1 ATRX MYO1D POLR2B CHD1 UNC45A GDI2 LDHB NDUFS1 PPP5C ANAPC1 INTS11 UTP20 CDC42 SEC61A1 ATP2A2 RAC1 HELLS | 3.54e-06 | 1425 | 150 | 20 | 30948266 |
| Pubmed | Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. | 4.33e-06 | 8 | 150 | 3 | 24598074 | |
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 15964829 | ||
| Pubmed | Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. | 4.33e-06 | 8 | 150 | 3 | 15249579 | |
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 27048830 | ||
| Pubmed | RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. | 4.33e-06 | 8 | 150 | 3 | 23706742 | |
| Pubmed | ATP13A4 ACACB MYO1D SMARCAL1 BARD1 SMOC2 NEB GDI1 AP3M1 NDUFS1 CHD6 SNTB2 HELLS | 4.35e-06 | 638 | 150 | 13 | 31182584 | |
| Pubmed | 4.45e-06 | 285 | 150 | 9 | 32838362 | ||
| Pubmed | KIF18A RIOK1 MYCBP2 ZNF174 POLR2B BARD1 MCM10 LCP1 CHD6 LRBA KIF18B SEC61A1 HELLS | 4.90e-06 | 645 | 150 | 13 | 25281560 | |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 11562357 | ||
| Pubmed | Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. | 6.48e-06 | 9 | 150 | 3 | 18180038 | |
| Pubmed | MYO1D DCTN5 POLR2B CHD9 UNC45A GDI1 GDI2 LDHB NDUFS1 PPP5C PIK3CA POP1 NFAT5 CDC42 SEC61A1 ATP2A2 RAC1 HELLS | 7.77e-06 | 1247 | 150 | 18 | 27684187 | |
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 34215617 | ||
| Pubmed | Regulation of lymphatic-blood vessel separation by endothelial Rac1. | 9.23e-06 | 10 | 150 | 3 | 19906871 | |
| Pubmed | 1.55e-05 | 183 | 150 | 7 | 36129980 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17356711 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26829882 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21622527 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31825077 | ||
| Pubmed | Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. | 1.85e-05 | 2 | 150 | 2 | 23677246 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15265891 | ||
| Pubmed | A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients. | 1.85e-05 | 2 | 150 | 2 | 26071482 | |
| Pubmed | Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. | 1.85e-05 | 2 | 150 | 2 | 14564009 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31369617 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21976675 | ||
| Pubmed | Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer. | 1.85e-05 | 2 | 150 | 2 | 28450422 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21940819 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26820533 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 36791204 | ||
| Pubmed | Two mammalian UNC-45 isoforms are related to distinct cytoskeletal and muscle-specific functions. | 1.85e-05 | 2 | 150 | 2 | 12356907 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 35563793 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12511425 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12391220 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26496249 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19948726 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8994833 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 7585614 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21949760 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31705628 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26582364 | ||
| Pubmed | Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. | 1.85e-05 | 2 | 150 | 2 | 19592621 | |
| Pubmed | Rac2 is required for the formation of neutrophil extracellular traps. | 1.85e-05 | 2 | 150 | 2 | 21712395 | |
| Pubmed | Unc45 activates Hsp90-dependent folding of the myosin motor domain. | 1.85e-05 | 2 | 150 | 2 | 18326487 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19710257 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15557338 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19709124 | ||
| Pubmed | Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor. | 1.85e-05 | 2 | 150 | 2 | 27355516 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 37871012 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31390560 | ||
| Pubmed | Rac-Dependent Signaling from Keratinocytes Promotes Differentiation of Intradermal White Adipocytes. | 1.85e-05 | 2 | 150 | 2 | 31351086 | |
| Pubmed | Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome. | 1.85e-05 | 2 | 150 | 2 | 31221776 | |
| Pubmed | [Research on Molecular Mechanisms of Engulfment of Apoptotic Cells]. | 1.85e-05 | 2 | 150 | 2 | 26234352 | |
| Pubmed | Specific roles of Rac1 and Rac2 in motile functions of HT1080 fibrosarcoma cells. | 1.85e-05 | 2 | 150 | 2 | 19555660 | |
| Pubmed | UCS proteins: chaperones for myosin and co-chaperones for Hsp90. | 1.85e-05 | 2 | 150 | 2 | 25487020 | |
| Pubmed | Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. | 1.85e-05 | 2 | 150 | 2 | 16025125 | |
| Pubmed | Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. | 1.85e-05 | 2 | 150 | 2 | 16027728 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9299243 | ||
| Pubmed | Transforming mutations of RAC guanosine triphosphatases in human cancers. | 1.85e-05 | 2 | 150 | 2 | 23382236 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12960245 | ||
| Pubmed | Activation of Rac2 and Cdc42 on Fc and complement receptor ligation in human neutrophils. | 1.85e-05 | 2 | 150 | 2 | 12960248 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16280046 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 36599922 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22023353 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 10087992 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21469092 | ||
| Pubmed | Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cells. | 1.85e-05 | 2 | 150 | 2 | 17244648 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34110575 | ||
| Interaction | RAB23 interactions | 1.33e-07 | 54 | 148 | 7 | int:RAB23 | |
| Interaction | SLC38A1 interactions | 4.72e-07 | 129 | 148 | 9 | int:SLC38A1 | |
| Interaction | SLITRK4 interactions | 1.16e-06 | 26 | 148 | 5 | int:SLITRK4 | |
| Interaction | ADCY9 interactions | 1.87e-06 | 152 | 148 | 9 | int:ADCY9 | |
| Interaction | FLRT2 interactions | 2.06e-06 | 29 | 148 | 5 | int:FLRT2 | |
| Interaction | SLC2A1 interactions | FASTKD1 COQ8B BTAF1 LDHB RND1 LAMP3 CDC42 RAC1 RAC2 HTT RAC3 | 2.19e-06 | 247 | 148 | 11 | int:SLC2A1 |
| Interaction | BSG interactions | GRK6 FASTKD1 BTAF1 GDI2 GPD1L RND1 PIK3CA LAMP3 UTP20 CDC42 SEC61A1 CFAP69 ATP2A2 RAC1 TBCD RAC2 RAC3 | 4.05e-06 | 631 | 148 | 17 | int:BSG |
| Interaction | DOCK9 interactions | 5.64e-06 | 61 | 148 | 6 | int:DOCK9 | |
| Interaction | MARK2 interactions | KIF13B NAP1L5 RND1 AGO1 LAMP3 CDC42 SNTB2 RAC1 RAC2 HTT RAC3 | 5.92e-06 | 274 | 148 | 11 | int:MARK2 |
| Interaction | MUC13 interactions | 7.20e-06 | 37 | 148 | 5 | int:MUC13 | |
| Interaction | GPR17 interactions | SLC2A8 FASTKD1 COQ8B BTAF1 GPD1L EXOC5 UTP20 LRBA ATP2A2 TBCD HTT | 8.04e-06 | 283 | 148 | 11 | int:GPR17 |
| Interaction | SLC11A2 interactions | 8.24e-06 | 38 | 148 | 5 | int:SLC11A2 | |
| Interaction | ALPL interactions | 9.40e-06 | 39 | 148 | 5 | int:ALPL | |
| Interaction | RAD51 interactions | ATRX MYCBP2 BARD1 RAD54L2 FBXO5 RAD54B GMEB1 SPIDR DNA2 CDC42 | 1.20e-05 | 241 | 148 | 10 | int:RAD51 |
| Interaction | CPNE8 interactions | 1.25e-05 | 105 | 148 | 7 | int:CPNE8 | |
| Interaction | SLC39A10 interactions | 1.32e-05 | 147 | 148 | 8 | int:SLC39A10 | |
| Interaction | SLC19A1 interactions | 1.37e-05 | 71 | 148 | 6 | int:SLC19A1 | |
| Interaction | ARHGDIB interactions | 1.53e-05 | 43 | 148 | 5 | int:ARHGDIB | |
| Interaction | C2CD2 interactions | 1.72e-05 | 44 | 148 | 5 | int:C2CD2 | |
| Interaction | MTMR1 interactions | 1.79e-05 | 111 | 148 | 7 | int:MTMR1 | |
| Interaction | AMIGO2 interactions | 2.65e-05 | 24 | 148 | 4 | int:AMIGO2 | |
| Interaction | CLDN3 interactions | 2.65e-05 | 24 | 148 | 4 | int:CLDN3 | |
| Interaction | LLGL1 interactions | 2.91e-05 | 164 | 148 | 8 | int:LLGL1 | |
| Interaction | BLTP1 interactions | 2.93e-05 | 49 | 148 | 5 | int:BLTP1 | |
| Interaction | SLC39A6 interactions | 3.31e-05 | 122 | 148 | 7 | int:SLC39A6 | |
| Interaction | ZDHHC8 interactions | 3.68e-05 | 26 | 148 | 4 | int:ZDHHC8 | |
| Interaction | SLC1A3 interactions | 3.85e-05 | 85 | 148 | 6 | int:SLC1A3 | |
| Interaction | KIF26B interactions | 3.93e-05 | 52 | 148 | 5 | int:KIF26B | |
| Interaction | GIT1 interactions | 4.09e-05 | 172 | 148 | 8 | int:GIT1 | |
| Interaction | VCP interactions | HK1 ATRX MYO1D MYCBP2 POLR2B BARD1 NEB WLS LDHB AP3M1 NDUFS1 PPP5C ANXA10 LRBA CDC42 SEC61A1 ATP2A2 SNTB2 RAC1 TBCD RAC2 HTT RAC3 PNP HELLS | 4.53e-05 | 1435 | 148 | 25 | int:VCP |
| Interaction | SLC12A4 interactions | 4.73e-05 | 129 | 148 | 7 | int:SLC12A4 | |
| Interaction | SH3BP4 interactions | 4.97e-05 | 130 | 148 | 7 | int:SH3BP4 | |
| Interaction | KCNJ12 interactions | 4.99e-05 | 28 | 148 | 4 | int:KCNJ12 | |
| Interaction | RAB8A interactions | 5.21e-05 | 178 | 148 | 8 | int:RAB8A | |
| Interaction | RAB12 interactions | 5.75e-05 | 29 | 148 | 4 | int:RAB12 | |
| Interaction | OLR1 interactions | 5.75e-05 | 29 | 148 | 4 | int:OLR1 | |
| Interaction | HLA-B interactions | 7.00e-05 | 239 | 148 | 9 | int:HLA-B | |
| Interaction | SLITRK5 interactions | 7.26e-05 | 59 | 148 | 5 | int:SLITRK5 | |
| Interaction | DCBLD1 interactions | 7.53e-05 | 31 | 148 | 4 | int:DCBLD1 | |
| Interaction | FERMT2 interactions | 7.94e-05 | 189 | 148 | 8 | int:FERMT2 | |
| Interaction | FAM83B interactions | 7.95e-05 | 140 | 148 | 7 | int:FAM83B | |
| Interaction | SLX4 interactions | KIF18A ACACB ATRX BARD1 CHD9 CHD8 CHD1 RAD54L2 MCM10 LDHB AP3M1 ZNF106 ATP2A2 HELLS | 8.46e-05 | 572 | 148 | 14 | int:SLX4 |
| Interaction | SLC16A7 interactions | 8.56e-05 | 32 | 148 | 4 | int:SLC16A7 | |
| Interaction | PLCB4 interactions | 8.56e-05 | 32 | 148 | 4 | int:PLCB4 | |
| Interaction | MKI67 interactions | KIF18A EXOSC9 SMARCAL1 BARD1 CHD8 UNC45A ZNF106 POLR3B FBXO5 POP1 OSBPL5 UTP20 KIF18B CDC42 ATP2A2 | 8.74e-05 | 648 | 148 | 15 | int:MKI67 |
| Interaction | DEPDC1B interactions | 8.87e-05 | 192 | 148 | 8 | int:DEPDC1B | |
| Interaction | ARL6IP5 interactions | 8.87e-05 | 192 | 148 | 8 | int:ARL6IP5 | |
| Interaction | ADD3 interactions | 9.49e-05 | 144 | 148 | 7 | int:ADD3 | |
| Interaction | PTGES3 interactions | KIF18A DCTN5 SMARCAL1 GRK6 POLR2B DIP2A POLR3B AGO1 PPP5C KIF18B DNA2 HTT | 9.51e-05 | 437 | 148 | 12 | int:PTGES3 |
| Interaction | SLC3A2 interactions | SLC7A7 SLC7A6 GPD1L RND1 LAMP3 CDC42 ATP2A2 RAC1 RAC2 HTT RAC3 | 9.80e-05 | 372 | 148 | 11 | int:SLC3A2 |
| Interaction | MPP7 interactions | 1.01e-04 | 101 | 148 | 6 | int:MPP7 | |
| Interaction | STEAP3 interactions | 1.03e-04 | 146 | 148 | 7 | int:STEAP3 | |
| Interaction | SLC6A15 interactions | 1.08e-04 | 147 | 148 | 7 | int:SLC6A15 | |
| Interaction | CTNNAL1 interactions | 1.16e-04 | 65 | 148 | 5 | int:CTNNAL1 | |
| Interaction | ATP11A interactions | 1.22e-04 | 35 | 148 | 4 | int:ATP11A | |
| Interaction | RASA3 interactions | 1.22e-04 | 35 | 148 | 4 | int:RASA3 | |
| Interaction | FLVCR1 interactions | 1.25e-04 | 105 | 148 | 6 | int:FLVCR1 | |
| Interaction | ACBD3 interactions | 1.29e-04 | 259 | 148 | 9 | int:ACBD3 | |
| Interaction | ZDHHC20 interactions | 1.37e-04 | 36 | 148 | 4 | int:ZDHHC20 | |
| Interaction | PCDH17 interactions | 1.37e-04 | 36 | 148 | 4 | int:PCDH17 | |
| Interaction | ADGRG6 interactions | 1.37e-04 | 36 | 148 | 4 | int:ADGRG6 | |
| Interaction | CTDSP1 interactions | 1.39e-04 | 107 | 148 | 6 | int:CTDSP1 | |
| Interaction | CD99 interactions | 1.43e-04 | 68 | 148 | 5 | int:CD99 | |
| Interaction | RAB32 interactions | 1.43e-04 | 68 | 148 | 5 | int:RAB32 | |
| Interaction | SLC20A2 interactions | 1.43e-04 | 68 | 148 | 5 | int:SLC20A2 | |
| Interaction | RAB4A interactions | KIF13B ATP7B WLS GDI1 GDI2 LDHB EXOC5 LRBA CDC42 CNN2 HTT PNP | 1.44e-04 | 457 | 148 | 12 | int:RAB4A |
| Interaction | RAB4B interactions | 1.53e-04 | 37 | 148 | 4 | int:RAB4B | |
| Interaction | BDKRB2 interactions | 1.53e-04 | 37 | 148 | 4 | int:BDKRB2 | |
| Interaction | AKAP12 interactions | 1.56e-04 | 156 | 148 | 7 | int:AKAP12 | |
| Interaction | RASAL2 interactions | 1.69e-04 | 158 | 148 | 7 | int:RASAL2 | |
| Interaction | EFR3A interactions | 1.70e-04 | 111 | 148 | 6 | int:EFR3A | |
| Interaction | SLC25A1 interactions | 1.76e-04 | 270 | 148 | 9 | int:SLC25A1 | |
| Interaction | XPR1 interactions | 1.79e-04 | 112 | 148 | 6 | int:XPR1 | |
| Interaction | FBXO22 interactions | RIOK1 ACACB POLR2B TOGARAM2 CHD9 NEB LCP1 AP3M1 ZNF106 DIP2A RBM46 LRBA HELLS | 1.80e-04 | 540 | 148 | 13 | int:FBXO22 |
| Interaction | EPB41L3 interactions | 1.86e-04 | 272 | 148 | 9 | int:EPB41L3 | |
| Interaction | SLC39A14 interactions | 1.88e-04 | 113 | 148 | 6 | int:SLC39A14 | |
| Interaction | PAK6 interactions | 2.01e-04 | 73 | 148 | 5 | int:PAK6 | |
| Interaction | SLC6A6 interactions | 2.08e-04 | 40 | 148 | 4 | int:SLC6A6 | |
| Interaction | PPP1R9B interactions | HK1 MYO1D MYCBP2 RBL1 CYP51A1 MCM10 GDI1 GDI2 LDHB NDUFS1 GPD1L CDC42 ATP2A2 RAC1 | 2.16e-04 | 626 | 148 | 14 | int:PPP1R9B |
| Interaction | VAMP7 interactions | 2.17e-04 | 116 | 148 | 6 | int:VAMP7 | |
| Interaction | NPTN interactions | 2.19e-04 | 278 | 148 | 9 | int:NPTN | |
| Interaction | PCDH7 interactions | 2.25e-04 | 279 | 148 | 9 | int:PCDH7 | |
| Interaction | SLC30A1 interactions | 2.38e-04 | 118 | 148 | 6 | int:SLC30A1 | |
| Interaction | SLC9A1 interactions | 2.38e-04 | 118 | 148 | 6 | int:SLC9A1 | |
| Interaction | POR interactions | 2.40e-04 | 222 | 148 | 8 | int:POR | |
| Interaction | RELL1 interactions | 2.42e-04 | 76 | 148 | 5 | int:RELL1 | |
| Interaction | PAK4 interactions | 2.56e-04 | 169 | 148 | 7 | int:PAK4 | |
| Interaction | NECTIN3 interactions | 2.74e-04 | 78 | 148 | 5 | int:NECTIN3 | |
| Interaction | PSD3 interactions | 2.74e-04 | 78 | 148 | 5 | int:PSD3 | |
| Interaction | TACC1 interactions | 2.74e-04 | 171 | 148 | 7 | int:TACC1 | |
| Interaction | JPH1 interactions | 2.88e-04 | 228 | 148 | 8 | int:JPH1 | |
| Interaction | CD80 interactions | 2.91e-04 | 79 | 148 | 5 | int:CD80 | |
| Interaction | GNB4 interactions | 2.97e-04 | 123 | 148 | 6 | int:GNB4 | |
| Interaction | KRIT1 interactions | 3.02e-04 | 44 | 148 | 4 | int:KRIT1 | |
| Interaction | GYPA interactions | 3.05e-04 | 174 | 148 | 7 | int:GYPA | |
| Interaction | FHOD1 interactions | 3.08e-04 | 80 | 148 | 5 | int:FHOD1 | |
| Interaction | CBARP interactions | 3.08e-04 | 80 | 148 | 5 | int:CBARP | |
| Interaction | CAVIN1 interactions | 3.15e-04 | 292 | 148 | 9 | int:CAVIN1 | |
| Interaction | PPFIBP1 interactions | 3.38e-04 | 177 | 148 | 7 | int:PPFIBP1 | |
| Interaction | ARHGDIG interactions | 3.45e-04 | 19 | 148 | 3 | int:ARHGDIG | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 9.20e-05 | 137 | 150 | 5 | chr9q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.53e-04 | 183 | 150 | 5 | chr16q22 | |
| Cytoband | 16q22.1 | 4.83e-04 | 110 | 150 | 4 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 6.70e-04 | 120 | 150 | 4 | chr4q32 | |
| GeneFamily | Rho family GTPases | 4.22e-08 | 20 | 91 | 5 | 390 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.34e-05 | 46 | 91 | 4 | 622 | |
| GeneFamily | RNA polymerase subunits | 4.10e-04 | 29 | 91 | 3 | 726 | |
| GeneFamily | Annexins|Endogenous ligands | 1.89e-03 | 13 | 91 | 2 | 404 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN | ZNF174 BARD1 MCM10 LCP1 TGFBI FBXO5 TLR4 RAD54B AP3M2 KIF18B DNA2 ATP2A2 CNN2 RAC2 HELLS | 4.53e-06 | 647 | 149 | 15 | M10351 |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN | 9.75e-06 | 24 | 149 | 4 | M34013 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 1.09e-05 | 184 | 149 | 8 | M6696 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KIF13B KIF18A EXOSC9 GRK5 SLC25A14 BARD1 MCM10 GDI2 LPAR1 EXOC5 CLCA1 FBXO5 PPP5C POP1 RAD54B KIF18B DNA2 ATP2A2 RAC1 PHLPP2 HELLS | 1.36e-05 | 1290 | 149 | 21 | M80 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | KIF18A ATRX RBL1 MCM10 SMOC2 SLC7A7 LPAR1 LEPR TGFBI TMTC1 LRRN3 TMTC4 GUCY1B1 ANAPC1 PIK3CA TLR4 RBM46 PAPPA NFAT5 | 2.90e-06 | 819 | 144 | 19 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | ATRX SMOC2 SLC7A7 LEPR TGFBI TMTC1 TMTC4 GUCY1B1 ANAPC1 TLR4 RBM46 PAPPA NFAT5 | 6.11e-06 | 421 | 144 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ATRX CHD9 CHD8 SMOC2 GDI1 SVEP1 TGFBI LRRN3 PIK3CA WDR35 GMEB1 RBM46 NFAT5 SEC61A1 SNTB2 HTT HELLS | 3.14e-05 | 801 | 144 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.22e-05 | 234 | 144 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 5.86e-05 | 61 | 144 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 9.21e-05 | 67 | 144 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.12e-04 | 275 | 144 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 1.41e-04 | 116 | 144 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.69e-04 | 41 | 144 | 4 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.20e-08 | 195 | 150 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-07 | 169 | 150 | 8 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-07 | 169 | 150 | 8 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-07 | 180 | 150 | 8 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 187 | 150 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.86e-07 | 191 | 150 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.86e-07 | 191 | 150 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-07 | 191 | 150 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 192 | 150 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.22e-07 | 194 | 150 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 195 | 150 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 195 | 150 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 159 | 150 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 159 | 150 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 165 | 150 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 169 | 150 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 169 | 150 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-06 | 172 | 150 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 173 | 150 | 7 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 179 | 150 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.18e-06 | 185 | 150 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.29e-06 | 186 | 150 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.92e-06 | 191 | 150 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-06 | 193 | 150 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.20e-06 | 193 | 150 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.35e-06 | 194 | 150 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.35e-06 | 194 | 150 | 7 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 4.50e-06 | 195 | 150 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.50e-06 | 195 | 150 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.81e-06 | 197 | 150 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.97e-06 | 198 | 150 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-06 | 198 | 150 | 7 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 4.97e-06 | 198 | 150 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 5.14e-06 | 199 | 150 | 7 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-05 | 159 | 150 | 6 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-05 | 159 | 150 | 6 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 162 | 150 | 6 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 162 | 150 | 6 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 162 | 150 | 6 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 163 | 150 | 6 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 163 | 150 | 6 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.92e-05 | 163 | 150 | 6 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 165 | 150 | 6 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 167 | 150 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 168 | 150 | 6 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 168 | 150 | 6 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 169 | 150 | 6 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.51e-05 | 171 | 150 | 6 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.68e-05 | 173 | 150 | 6 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-05 | 173 | 150 | 6 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 174 | 150 | 6 | b4aecc56986ed29bbaf84773a48cf4725845ff9d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-05 | 175 | 150 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 2.86e-05 | 175 | 150 | 6 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-05 | 175 | 150 | 6 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | a5ec032fe39172be11ffdda5af515c8d38731d9a | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | b1b921f96b6a3cbfbd156d7b74f06c82c4e199d0 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 179 | 150 | 6 | 02218c048e4dec0c0a3d63d2abb4feb4c3e82697 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 180 | 150 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.67e-05 | 183 | 150 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.67e-05 | 183 | 150 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-21m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 150 | 6 | 71ea92cd20683230af314ff883b2624bd68382e1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 184 | 150 | 6 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 184 | 150 | 6 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.90e-05 | 185 | 150 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 185 | 150 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 185 | 150 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 4.14e-05 | 187 | 150 | 6 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 187 | 150 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.40e-05 | 189 | 150 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 4.40e-05 | 189 | 150 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 190 | 150 | 6 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.53e-05 | 190 | 150 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.53e-05 | 190 | 150 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.53e-05 | 190 | 150 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 191 | 150 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 191 | 150 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.66e-05 | 191 | 150 | 6 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.66e-05 | 191 | 150 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.66e-05 | 191 | 150 | 6 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.80e-05 | 192 | 150 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 4.94e-05 | 193 | 150 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 4.94e-05 | 193 | 150 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.08e-05 | 194 | 150 | 6 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.08e-05 | 194 | 150 | 6 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 5.08e-05 | 194 | 150 | 6 | 28d19105123b015f8aa25ea8e6c078f630d4ba80 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.23e-05 | 195 | 150 | 6 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-05 | 195 | 150 | 6 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| Drug | geranylgeranyl pyrophosphate | 3.81e-06 | 139 | 149 | 8 | CID000000735 | |
| Drug | B258 | 5.41e-06 | 6 | 149 | 3 | CID000593690 | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 4.26e-06 | 7 | 148 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Ventricular Dysfunction, Left | 1.50e-05 | 30 | 148 | 4 | C0242698 | |
| Disease | triglyceride measurement, C-reactive protein measurement | 3.93e-05 | 38 | 148 | 4 | EFO_0004458, EFO_0004530 | |
| Disease | kidney disease (implicated_via_orthology) | 5.33e-05 | 41 | 148 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 5.38e-05 | 15 | 148 | 3 | OBA_2045165 | |
| Disease | cholelithiasis | 8.31e-05 | 88 | 148 | 5 | EFO_0004799 | |
| Disease | Fatty Liver | 8.31e-05 | 88 | 148 | 5 | C0015695 | |
| Disease | Steatohepatitis | 8.31e-05 | 88 | 148 | 5 | C2711227 | |
| Disease | Malignant neoplasm of breast | ATP7B SMARCAL1 BARD1 AQP8 SLC7A7 LDHB LPAR1 LEPR TMTC4 PIK3CA UNC45B POP1 SLC10A6 UTP20 LRBA RAC2 | 1.03e-04 | 1074 | 148 | 16 | C0006142 |
| Disease | Cholecystitis | 1.13e-04 | 19 | 148 | 3 | HP_0001082 | |
| Disease | mean platelet volume | LNX2 GRK4 GRK5 CHD9 GCKR SMOC2 LCP1 LEPR SVEP1 KCNQ1 MUSK CNN2 TBCD RAC2 HTT | 1.97e-04 | 1020 | 148 | 15 | EFO_0004584 |
| Disease | gallstones | 2.18e-04 | 108 | 148 | 5 | EFO_0004210 | |
| Disease | level of lipoprotein lipase in blood serum | 2.47e-04 | 5 | 148 | 2 | OBA_2042223 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | leptin receptor measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0004635 | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 2.47e-04 | 5 | 148 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | diacylglycerol 34:2 measurement | 2.62e-04 | 25 | 148 | 3 | EFO_0010353 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 3.31e-04 | 27 | 148 | 3 | C1112155 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 3.70e-04 | 6 | 148 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | plasma serine protease inhibitor measurement | 3.70e-04 | 6 | 148 | 2 | EFO_0020642 | |
| Disease | Abnormal muscle tone | 3.70e-04 | 6 | 148 | 2 | C0852413 | |
| Disease | response to surgery, post-operative sign or symptom | 3.70e-04 | 6 | 148 | 2 | EFO_0005323, EFO_0009951 | |
| Disease | triacylglycerol 56:7 measurement | 4.11e-04 | 29 | 148 | 3 | EFO_0010434 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 4.11e-04 | 29 | 148 | 3 | C1333990 | |
| Disease | Intellectual Disability | 4.45e-04 | 447 | 148 | 9 | C3714756 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.67e-04 | 195 | 148 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Liver diseases | 4.80e-04 | 72 | 148 | 4 | C0023895 | |
| Disease | Liver Dysfunction | 4.80e-04 | 72 | 148 | 4 | C0086565 | |
| Disease | Solid Neoplasm | 5.16e-04 | 7 | 148 | 2 | C0280100 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.34e-04 | 200 | 148 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Acute Coronary Syndrome | 6.04e-04 | 33 | 148 | 3 | C0948089 | |
| Disease | alkaline phosphatase measurement | ACACB GCKR LCP1 LEPR KIF9 GFOD2 TM4SF4 ABCB11 SLC13A5 LRBA NFAT5 CDC42 MUSK PHLPP2 | 6.11e-04 | 1015 | 148 | 14 | EFO_0004533 |
| Disease | fasting blood glucose measurement | 6.37e-04 | 287 | 148 | 7 | EFO_0004465 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 6.86e-04 | 8 | 148 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | thrombin measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0020768 | |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0800455 | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 6.86e-04 | 8 | 148 | 2 | OBA_2045166 | |
| Disease | phospholipid measurement | 7.19e-04 | 140 | 148 | 5 | EFO_0004639 | |
| Disease | interleukin 16 measurement | 7.82e-04 | 36 | 148 | 3 | EFO_0008173 | |
| Disease | Growth Disorders | 7.82e-04 | 36 | 148 | 3 | C0018273 | |
| Disease | triglyceride measurement, blood pressure | 8.79e-04 | 9 | 148 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | Autism Spectrum Disorders | 8.98e-04 | 85 | 148 | 4 | C1510586 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 9.20e-04 | 222 | 148 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 9.38e-04 | 86 | 148 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.80e-04 | 150 | 148 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.04e-03 | 152 | 148 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.07e-03 | 153 | 148 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0800608 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0800507 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.10e-03 | 10 | 148 | 2 | OBA_2045163 | |
| Disease | diacylglycerol 32.2 measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0020055 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.23e-03 | 42 | 148 | 3 | EFO_0022255 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.23e-03 | 42 | 148 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | triacylglycerol 56:6 measurement | 1.32e-03 | 43 | 148 | 3 | EFO_0010433 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.32e-03 | 43 | 148 | 3 | EFO_0022278 | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0800269 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0801871 | |
| Disease | Neuroendocrine Tumors | 1.33e-03 | 11 | 148 | 2 | C0206754 | |
| Disease | diacylglycerol 34:3 measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0020059 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.54e-03 | 166 | 148 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0008258 | |
| Disease | triacylglycerol 54:9 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0010427 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0010378 | |
| Disease | triacylglycerol 53:2 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0021484 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0800453 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 1.60e-03 | 12 | 148 | 2 | OBA_2045171 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 1.60e-03 | 12 | 148 | 2 | OBA_2045074 | |
| Disease | non-alcoholic steatohepatitis | 1.60e-03 | 12 | 148 | 2 | EFO_1001249 | |
| Disease | Heart Diseases | 1.60e-03 | 46 | 148 | 3 | C0018799 | |
| Disease | triacylglycerol 54:4 measurement | 1.60e-03 | 46 | 148 | 3 | EFO_0010422 | |
| Disease | Neuroblastoma | 1.71e-03 | 47 | 148 | 3 | C0027819 | |
| Disease | transmembrane protein 87B measurement | 1.88e-03 | 13 | 148 | 2 | EFO_0802158 | |
| Disease | tRNA (guanine-N(7)-)-methyltransferase measurement | 1.88e-03 | 13 | 148 | 2 | EFO_0802162 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.88e-03 | 13 | 148 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.88e-03 | 13 | 148 | 2 | OBA_2045082 | |
| Disease | apolipoprotein B measurement | 1.95e-03 | 663 | 148 | 10 | EFO_0004615 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.03e-03 | 106 | 148 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.04e-03 | 50 | 148 | 3 | EFO_0022303 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.16e-03 | 51 | 148 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Malformations of Cortical Development | 2.19e-03 | 14 | 148 | 2 | C1955869 | |
| Disease | Diabetic Neuralgia | 2.19e-03 | 14 | 148 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 2.19e-03 | 14 | 148 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 2.19e-03 | 14 | 148 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 2.19e-03 | 14 | 148 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 2.19e-03 | 14 | 148 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 2.19e-03 | 14 | 148 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 2.19e-03 | 14 | 148 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 2.19e-03 | 14 | 148 | 2 | C0271680 | |
| Disease | Adenocarcinoma Of Esophagus | 2.19e-03 | 14 | 148 | 2 | C0279628 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 2.19e-03 | 14 | 148 | 2 | OBA_2045143 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 2.19e-03 | 14 | 148 | 2 | C0393835 | |
| Disease | Cortical Dysplasia | 2.19e-03 | 14 | 148 | 2 | C0431380 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.22e-03 | 264 | 148 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.32e-03 | 110 | 148 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.32e-03 | 110 | 148 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.32e-03 | 110 | 148 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 2.51e-03 | 15 | 148 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | quinate measurement | 2.51e-03 | 15 | 148 | 2 | EFO_0021167 | |
| Disease | triacylglycerol 52:3 measurement | 2.51e-03 | 15 | 148 | 2 | EFO_0010415 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILKSAMCAEAIVAGL | 311 | Q15582 | |
| NCILADEMGLGKTIQ | 831 | Q9HCK8 | |
| KQIFMEIVGVQSALC | 1171 | Q9P2K9 | |
| AMKGVGTDENCLIEI | 101 | Q9UJ72 | |
| GDAVQSTLKCMLGIL | 611 | Q99728 | |
| AALEDCMGKLQLLVA | 311 | P22674 | |
| LILTGNKVLMPCDAV | 286 | Q4VNC1 | |
| GVLCGMIAIADAVKQ | 1186 | P35670 | |
| KRVGDTLLGMATQCV | 531 | Q9UL18 | |
| SARCLMEGKQLLVVG | 386 | A5YM72 | |
| GTRCGLLNIESEMIK | 126 | O95342 | |
| TLLALAVCMGAINEK | 166 | O94778 | |
| ACKGMGTNEAAIIEI | 26 | P27216 | |
| CILAHSMGLGKTLQV | 301 | Q9Y4B4 | |
| LKGEVCFNMGQIVLA | 1136 | Q96PN6 | |
| EIQGVIDACIKLSGM | 201 | Q9Y2T2 | |
| LEMEIISCGNITDKG | 156 | Q99766 | |
| SCILADEMGLGKTIQ | 501 | O14646 | |
| DEMGLGKTLQCISLI | 326 | Q9Y620 | |
| MNGKCIDGASIEVTL | 291 | Q8TBY0 | |
| MQAIKCVVVGDGAVG | 1 | P15153 | |
| MQAIKCVVVGDGAVG | 1 | P60763 | |
| SDGVVILLLGNKMDC | 936 | Q7Z6P3 | |
| MQAIKCVVVGDGAVG | 1 | P63000 | |
| IMLGVVCGALNVADA | 771 | O00763 | |
| EELKLNTLMGEGICS | 771 | Q9H1A4 | |
| NTLMGEGICSLVELL | 776 | Q9H1A4 | |
| EIQGVIDACVKLTGM | 201 | P53677 | |
| IVLALGATQMALGCL | 31 | O60320 | |
| ECILSGIMSVNGKKV | 16 | P50395 | |
| LADEMGLGKTVQCIA | 246 | Q9NRZ9 | |
| GLGKTVQCIATIALM | 251 | Q9NRZ9 | |
| VVASMVVLCVGSKGQ | 206 | P51787 | |
| LVDTIKCLIQMGAAV | 591 | Q9BYH8 | |
| KGIADVGLMEEVVCN | 261 | Q9Y692 | |
| GRSCILVSIAGKNVM | 16 | Q5TA45 | |
| CGDNTKAAVIRLGLM | 221 | Q8N335 | |
| LKDSLGGNCQTIMIA | 316 | Q8NI77 | |
| LESKGMSLCQTVVVG | 236 | Q8N3F9 | |
| KCGDMIVAVNGLSTV | 646 | Q8N448 | |
| NTVSKLVMGLGITVC | 46 | Q92633 | |
| KLQVEMVGLTACLKA | 636 | Q8IY21 | |
| ICTIQSSGGIMLLKD | 231 | Q06265 | |
| SSGGIMLLKDQVLRC | 236 | Q06265 | |
| AVGDGIVLCKMINLS | 156 | P13796 | |
| ICNVMALEIKQLLAG | 106 | A6NFA0 | |
| GQELLIEGTSLVCMK | 1831 | P50851 | |
| NDTLLMCLKITSGGV | 206 | P48357 | |
| LNGSRLCIKAEMGIQ | 231 | Q9UQV4 | |
| VLLDQGGVKLFQEMC | 191 | Q86UY5 | |
| LTGTEISCLRLKGQM | 296 | Q02153 | |
| QKVLIMGEALDLGTC | 376 | Q7L590 | |
| MQTIKCVVVGDGAVG | 1 | P60953 | |
| LKDSLGGNCNMVLVT | 301 | Q9HAQ2 | |
| ILAVMKLACADISGN | 181 | Q8NGS8 | |
| LTQKCKVLMLGGSAL | 231 | Q13219 | |
| AQLCGAGMAAVVDKI | 831 | P19367 | |
| LLKDSLGGNCRTVMI | 311 | Q86Y91 | |
| NNMTLAVDCVGILKL | 376 | O94916 | |
| TIMQIQCKGGLKGAL | 856 | P42336 | |
| QTLGIIAIMDGVECI | 336 | Q14397 | |
| EILKALSGMCNIDTG | 261 | Q99575 | |
| MKLSLTKVVNGCRLG | 1 | Q9H974 | |
| KQLVETVSCGGNLLM | 321 | Q9BTY2 | |
| KLDTGIDRTLNCMIG | 531 | O00471 | |
| IMITGDNKGTAVAIC | 621 | P16615 | |
| ILAHCMGLGKTLQVV | 1591 | P46100 | |
| CILADEMGLGKTIQS | 881 | Q3L8U1 | |
| NKCVILALVIAISMG | 216 | Q9ULG6 | |
| IQLCDGIMASGRKAV | 1521 | P42858 | |
| LSSLGNCAVMGVIVK | 116 | Q8IZ08 | |
| DDMGLGKTLQSICIL | 1291 | O14981 | |
| NCILADEMGLGKTIQ | 481 | Q8TD26 | |
| MGTIAKACLQGSDLL | 1246 | Q8WZ74 | |
| LQNIIGRKMGLECVD | 231 | Q9UKT4 | |
| KAIVEVAAMCGVNII | 101 | Q9UBR1 | |
| ISMALCKNIGVDDVG | 946 | Q6ZRK6 | |
| KVTGGNLLSMLLIAC | 26 | Q16850 | |
| MLAEVLGGINCVKAS | 706 | Q53R41 | |
| ISVKALGIGKNVVCE | 81 | Q3B7J2 | |
| LCTVRGAALKVGQML | 146 | Q96D53 | |
| ALDIICETAMGKNIG | 196 | Q6ZWL3 | |
| LNGKTIVMNDCIIRG | 36 | Q9BTE1 | |
| QVGMACAISILGKSL | 31 | P07195 | |
| SILAGCIQMVLGQIE | 1121 | Q8IWT3 | |
| LCFKIKNNMVGVVIG | 51 | Q86TM3 | |
| MGRLAQEVLGCQAKL | 176 | Q5BKX5 | |
| ECILSGIMSVNGKKV | 16 | P31150 | |
| QTGVLRMKGVNLSCV | 1261 | Q14689 | |
| TKDALCLVLTIMNGG | 256 | P32298 | |
| KDALCLVLTIMNGGD | 256 | P34947 | |
| KDALCLVLTLMNGGD | 256 | P43250 | |
| DLCEKGTIQQMIGIF | 501 | A5D8W1 | |
| GSCIGNLIRMEHVKI | 476 | P51530 | |
| CQIKDMVKAGLGVNV | 576 | Q9UKG4 | |
| VKTGVIMNIIGVFCV | 526 | Q86YT5 | |
| MLQDTVLAAGCKQIL | 606 | Q9NVU0 | |
| CRVLQKLGADAVGMS | 206 | P00491 | |
| ACTLLGNVSILVAVM | 36 | Q8NH80 | |
| TMTLELGGKVTIECA | 546 | Q9H0X9 | |
| LINALGQVKMCDFGI | 186 | P52564 | |
| ILAVMKLACADISGN | 181 | Q8NGT0 | |
| VICQLKGGTQMLCID | 211 | Q9Y4I5 | |
| CLVKGSLGMNIVSSI | 156 | Q9NXJ0 | |
| VLVQTMGAPALKICD | 1516 | Q9NQT8 | |
| FKMLTRGIITEINGC | 171 | Q9BRS2 | |
| GALCKMVLTATVLNV | 111 | Q8TDU9 | |
| CLGSMDVKVITGALQ | 2121 | O75691 | |
| SCVINIGVAKNLDML | 196 | Q8IYX1 | |
| CNMSGLITIVVLLGI | 171 | Q96BY9 | |
| SRMEGVGQLLELCKA | 781 | Q6ZUX3 | |
| CIATNLVGADLKSVM | 496 | Q9H3W5 | |
| GLEKTCSQMAGVVQL | 326 | Q96ER9 | |
| GTTVLQACEKVGMQI | 46 | P28331 | |
| NIMKILKGIGETFCQ | 426 | P28749 | |
| LVLVGDVQCGKTAML | 16 | Q92730 | |
| LLAKIQELTGEMEGC | 116 | Q96NT1 | |
| AQCINGKVLIMHGGL | 341 | P53041 | |
| LLGSCVQLMVVVGIL | 156 | Q9NY64 | |
| LADDMGLGKTIQAIC | 456 | Q9NZC9 | |
| MTIGHLIECLQGKVS | 976 | P30876 | |
| ELANLGGVCAAALMK | 2161 | O75592 | |
| QGFILSGVKEMLRCT | 531 | Q4LDE5 | |
| GKAICRVVMTVDGIN | 111 | P30874 | |
| IVCLVLDKSGSMATG | 306 | A8K7I4 | |
| QKGLKDGTILCTLMN | 51 | Q99439 | |
| LLINMICGVVSGVIS | 141 | O95258 | |
| VAMLCKEQGITVLGL | 216 | Q5T4D3 | |
| LKAGVISALACMVKA | 626 | Q8IWX7 | |
| LALDGVGTMVNCTIK | 11 | Q9UN79 | |
| VLQKSLQECLGMGSG | 111 | Q9H0M4 | |
| LGTCAMLVKETGITV | 211 | Q8IUR5 | |
| AVCMQGQKVLLEKTG | 136 | Q15697 | |
| VVMAGNCLEVLNLGV | 396 | Q6ZVD8 | |
| LGCNLLIKSEGMINF | 76 | Q9NS64 | |
| SEMGAGICLLITIQL | 141 | P61619 | |
| QLEGKSCSLVGMKVL | 541 | Q14159 | |
| DKSISVQELMGCLGV | 401 | Q9H3U7 | |
| EISLLNGVCLIVGNM | 36 | Q9UM01 | |
| SLKPVQAIAVLIMGC | 91 | Q3KNW5 | |
| EGEACGLVKNLALMT | 486 | Q9NW08 | |
| IIVMGLVKLCQGHSE | 206 | Q92536 | |
| QKLLSGIAVFCEMVQ | 1086 | Q9BTW9 | |
| IENMSTKKLCIVGGI | 6 | Q5T9L3 | |
| IKMKLSCLVNVTGAI | 191 | Q9P2L0 | |
| ELIKEVSLGCMLNGQ | 441 | Q13425 | |
| NVMKTCIQGLAGLEV | 241 | O00206 | |
| SILLVVGGIQMVLCA | 161 | P48230 | |
| VNILGKVMVTACLDK | 1746 | Q9H2Y7 | |
| VKDCALMVEGSGLLQ | 636 | O95932 | |
| VKKLLAAGVVSAMVC | 636 | Q9H3U1 | |
| GKLDLCGENVIEVMS | 86 | Q8NAP8 | |
| GIIAILDDACMNVGK | 451 | O94832 | |
| CLVGENMVVKIADFG | 731 | O15146 | |
| KSIGALEVACGIVMT | 66 | Q53FP2 | |
| MLGVVLAKKCQTLVS | 2606 | P20929 | |
| DMLGVVLAKKCQTLV | 3091 | P20929 |